ROSUVASTATIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 39 adverse event reports in the FDA FAERS database where ROSUVASTATIN was used for Psoriasis.
Most Reported Side Effects for ROSUVASTATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 3,958 | 10.9% | 29 | 610 |
| Dyspnoea | 2,832 | 7.8% | 47 | 999 |
| Pain | 2,758 | 7.6% | 20 | 868 |
| Drug ineffective | 2,347 | 6.5% | 41 | 706 |
| Fatigue | 2,208 | 6.1% | 28 | 661 |
| Rhabdomyolysis | 2,173 | 6.0% | 134 | 1,555 |
| Arthralgia | 1,879 | 5.2% | 1 | 226 |
| Asthma | 1,843 | 5.1% | 31 | 511 |
| Muscle spasms | 1,843 | 5.1% | 3 | 242 |
| Pain in extremity | 1,686 | 4.6% | 5 | 248 |
| Drug hypersensitivity | 1,669 | 4.6% | 19 | 214 |
| Cough | 1,656 | 4.6% | 7 | 522 |
| Headache | 1,651 | 4.5% | 22 | 577 |
| Off label use | 1,594 | 4.4% | 29 | 554 |
| Acute kidney injury | 1,568 | 4.3% | 100 | 1,193 |
Other Indications for ROSUVASTATIN
Product used for unknown indication (11,569)
Blood cholesterol increased (3,321)
Hypercholesterolaemia (2,690)
Dyslipidaemia (2,032)
Hyperlipidaemia (1,591)
Blood cholesterol abnormal (1,590)
Blood cholesterol (975)
Coronary artery disease (600)
Type iia hyperlipidaemia (547)
Cerebrovascular accident (515)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)